We estimate that MRD represents a $20+ billion addressable market, growing at 30% annually, which we believe is less than 10% penetratedFORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: ...
Molecular testing, or molecular diagnostics, refers to a group of tests that look at the genetic material in a specimen. It can detect genetic risk factors for certain diseases or provide evidence of ...
IVDR: where are we now in molecular testing? How IVDR implementation is progressing in molecular biology laboratories in different European countries IVDR, the new EU legislation for in-vitro ...
cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...
"We're thrilled to partner with Molecular Lab Partners to bring rapid, scalable solutions to POLs and urgent care labs nationwide. Together, we're helping to advance diagnostics by making operations ...
Streamlining Respiratory Virus Testing with Molecular Diagnostics: Impact on patients and laboratory
Join us for an insightful webinar on the critical role of molecular diagnostic testing for respiratory viruses during flu season. This session will explore the importance of accurate and timely ...
Please provide your email address to receive an email when new articles are posted on . Precision medicine has shown great potential to improve treatment outcomes and prolong survival of patients with ...
Global Molecular Infectious Disease Testing Market OverviewThe global molecular infectious disease testing market is ...
A new standard in wheat immune reactivity testing that adds seven new wheat markers to assess immune responses to ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company, which helps ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results